Concepts (325)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Camelus | 13 | 2019 | 1425 | 1.75 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 23 | 2020 | 8843 | 1.04 | Why? |
| Animal Diseases | 2 | 2016 | 182 | 0.60 | Why? |
| Coronavirus | 21 | 2020 | 18339 | 0.57 | Why? |
| Antibodies, Viral | 26 | 2021 | 51949 | 0.50 | Why? |
| Cysteine Endopeptidases | 2 | 2018 | 1557 | 0.47 | Why? |
| Chiroptera | 8 | 2020 | 3530 | 0.44 | Why? |
| Coronaviridae Infections | 1 | 2014 | 442 | 0.40 | Why? |
| Dipeptidyl Peptidase 4 | 4 | 2020 | 1061 | 0.39 | Why? |
| SARS Virus | 11 | 2020 | 13021 | 0.36 | Why? |
| Viral Regulatory and Accessory Proteins | 1 | 2013 | 482 | 0.36 | Why? |
| Diagnostic Tests, Routine | 2 | 2021 | 2643 | 0.33 | Why? |
| Viral Plaque Assay | 1 | 2008 | 381 | 0.32 | Why? |
| Disease Reservoirs | 6 | 2020 | 1672 | 0.31 | Why? |
| Animals | 39 | 2021 | 78931 | 0.31 | Why? |
| Zoonoses | 6 | 2020 | 3034 | 0.30 | Why? |
| Virus Attachment | 1 | 2012 | 1259 | 0.29 | Why? |
| Virus Replication | 12 | 2020 | 14331 | 0.29 | Why? |
| Glycoproteins | 1 | 2010 | 615 | 0.28 | Why? |
| Coronavirus Infections | 44 | 2020 | 253789 | 0.28 | Why? |
| Open Reading Frames | 2 | 2021 | 1898 | 0.28 | Why? |
| Virology | 1 | 2008 | 489 | 0.27 | Why? |
| Host Specificity | 4 | 2018 | 926 | 0.26 | Why? |
| Viral Proteins | 4 | 2020 | 7370 | 0.26 | Why? |
| Sequence Homology, Amino Acid | 2 | 2018 | 945 | 0.25 | Why? |
| Interferon Type I | 2 | 2013 | 2789 | 0.25 | Why? |
| Autophagy | 2 | 2021 | 960 | 0.25 | Why? |
| Middle East | 5 | 2014 | 1418 | 0.25 | Why? |
| Spermine | 1 | 2021 | 41 | 0.23 | Why? |
| Antinematodal Agents | 1 | 2021 | 41 | 0.23 | Why? |
| Spermidine | 1 | 2021 | 56 | 0.23 | Why? |
| Receptors, Virus | 5 | 2020 | 5659 | 0.22 | Why? |
| Viral Matrix Proteins | 1 | 2010 | 1243 | 0.22 | Why? |
| Virion | 1 | 2010 | 1444 | 0.22 | Why? |
| Antibodies, Neutralizing | 9 | 2021 | 25288 | 0.22 | Why? |
| Autophagosomes | 1 | 2021 | 154 | 0.21 | Why? |
| Cell Line | 13 | 2020 | 12040 | 0.21 | Why? |
| Kenya | 4 | 2018 | 887 | 0.21 | Why? |
| S-Phase Kinase-Associated Proteins | 1 | 2019 | 12 | 0.21 | Why? |
| Autophagy-Related Proteins | 1 | 2021 | 157 | 0.21 | Why? |
| Beclin-1 | 1 | 2019 | 38 | 0.21 | Why? |
| Niclosamide | 1 | 2021 | 153 | 0.20 | Why? |
| Synthetic Biology | 1 | 2020 | 99 | 0.20 | Why? |
| Virus Internalization | 8 | 2020 | 7921 | 0.19 | Why? |
| Cloning, Molecular | 2 | 2020 | 1036 | 0.19 | Why? |
| Severe Acute Respiratory Syndrome | 5 | 2018 | 12361 | 0.19 | Why? |
| Geography | 2 | 2014 | 1801 | 0.18 | Why? |
| Porcine Reproductive and Respiratory Syndrome | 1 | 2017 | 47 | 0.18 | Why? |
| Myxovirus Resistance Proteins | 1 | 2017 | 77 | 0.17 | Why? |
| Caco-2 Cells | 5 | 2016 | 1236 | 0.17 | Why? |
| Porcine respiratory and reproductive syndrome virus | 1 | 2017 | 91 | 0.17 | Why? |
| Rodentia | 1 | 2019 | 235 | 0.16 | Why? |
| Molecular Sequence Data | 5 | 2014 | 3198 | 0.16 | Why? |
| RNA Viruses | 2 | 2017 | 824 | 0.16 | Why? |
| Goats | 2 | 2014 | 217 | 0.16 | Why? |
| Population Groups | 1 | 2019 | 212 | 0.16 | Why? |
| Metabolome | 1 | 2021 | 624 | 0.16 | Why? |
| Vero Cells | 9 | 2020 | 14117 | 0.16 | Why? |
| Ubiquitin | 1 | 2018 | 243 | 0.16 | Why? |
| Reverse Genetics | 1 | 2020 | 439 | 0.16 | Why? |
| Serine Endopeptidases | 4 | 2020 | 4606 | 0.16 | Why? |
| Genome, Viral | 4 | 2020 | 13157 | 0.15 | Why? |
| Amino Acid Sequence | 3 | 2018 | 6049 | 0.15 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2021 | 4545 | 0.15 | Why? |
| Seroconversion | 3 | 2021 | 2515 | 0.15 | Why? |
| Coronavirus 229E, Human | 3 | 2020 | 1241 | 0.15 | Why? |
| Host-Pathogen Interactions | 8 | 2020 | 11041 | 0.14 | Why? |
| Africa, Eastern | 1 | 2014 | 90 | 0.14 | Why? |
| Immunity, Innate | 1 | 2013 | 6570 | 0.14 | Why? |
| Abattoirs | 1 | 2015 | 94 | 0.14 | Why? |
| Proprotein Convertases | 1 | 2014 | 28 | 0.14 | Why? |
| Immunoglobulin A | 4 | 2021 | 3567 | 0.14 | Why? |
| Saudi Arabia | 5 | 2019 | 4423 | 0.14 | Why? |
| Organoids | 1 | 2021 | 840 | 0.14 | Why? |
| Respiratory Syncytial Viruses | 2 | 2020 | 612 | 0.14 | Why? |
| Virulence | 2 | 2020 | 2172 | 0.14 | Why? |
| Animal Husbandry | 1 | 2015 | 162 | 0.14 | Why? |
| Alphacoronavirus | 1 | 2019 | 392 | 0.13 | Why? |
| Ubiquitin-Protein Ligases | 1 | 2016 | 249 | 0.13 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2016 | 310 | 0.13 | Why? |
| Cells, Cultured | 3 | 2021 | 5835 | 0.13 | Why? |
| Horse Diseases | 1 | 2015 | 101 | 0.13 | Why? |
| Immunoglobulin G | 9 | 2021 | 21571 | 0.13 | Why? |
| Immune Sera | 1 | 2018 | 884 | 0.13 | Why? |
| Cricetinae | 1 | 2021 | 3344 | 0.13 | Why? |
| Interferons | 2 | 2018 | 2885 | 0.12 | Why? |
| Horses | 1 | 2015 | 474 | 0.12 | Why? |
| Serogroup | 1 | 2015 | 510 | 0.12 | Why? |
| Epithelial Cells | 3 | 2013 | 3508 | 0.12 | Why? |
| Drug Resistance, Viral | 1 | 2019 | 1083 | 0.12 | Why? |
| Membrane Glycoproteins | 2 | 2011 | 2273 | 0.12 | Why? |
| Enzyme-Linked Immunosorbent Assay | 6 | 2020 | 7868 | 0.12 | Why? |
| RNA, Double-Stranded | 1 | 2013 | 226 | 0.11 | Why? |
| Viral Envelope Proteins | 3 | 2020 | 3539 | 0.11 | Why? |
| HEK293 Cells | 4 | 2019 | 8394 | 0.11 | Why? |
| Breeding | 1 | 2011 | 60 | 0.11 | Why? |
| Cyclophilins | 1 | 2011 | 76 | 0.11 | Why? |
| Seroepidemiologic Studies | 6 | 2021 | 10017 | 0.11 | Why? |
| Coronavirus NL63, Human | 2 | 2020 | 669 | 0.11 | Why? |
| Humans | 55 | 2021 | 930598 | 0.11 | Why? |
| Evolution, Molecular | 3 | 2020 | 3691 | 0.11 | Why? |
| Blotting, Western | 2 | 2011 | 863 | 0.11 | Why? |
| Phenotype | 2 | 2020 | 4037 | 0.11 | Why? |
| Phylogeny | 7 | 2019 | 13341 | 0.11 | Why? |
| Proteome | 1 | 2021 | 1812 | 0.11 | Why? |
| History, 21st Century | 2 | 2016 | 1849 | 0.10 | Why? |
| Mammals | 1 | 2012 | 315 | 0.10 | Why? |
| Reagent Kits, Diagnostic | 1 | 2021 | 2149 | 0.10 | Why? |
| Neutralization Tests | 6 | 2021 | 6698 | 0.10 | Why? |
| RNA, Viral | 11 | 2021 | 32276 | 0.10 | Why? |
| Protease Inhibitors | 4 | 2020 | 3630 | 0.10 | Why? |
| Spike Glycoprotein, Coronavirus | 7 | 2021 | 37182 | 0.10 | Why? |
| Dexamethasone | 1 | 2021 | 2055 | 0.10 | Why? |
| Golgi Apparatus | 1 | 2010 | 178 | 0.10 | Why? |
| Occupations | 1 | 2015 | 733 | 0.10 | Why? |
| Blood Donors | 2 | 2021 | 2956 | 0.10 | Why? |
| Microscopy, Fluorescence | 1 | 2010 | 335 | 0.09 | Why? |
| Fluorescent Antibody Technique | 3 | 2019 | 835 | 0.09 | Why? |
| Viral Tropism | 2 | 2014 | 1329 | 0.09 | Why? |
| Tacrolimus | 1 | 2012 | 435 | 0.09 | Why? |
| Population Density | 1 | 2014 | 694 | 0.09 | Why? |
| Dendritic Cells | 1 | 2017 | 1330 | 0.09 | Why? |
| Africa | 3 | 2019 | 2986 | 0.09 | Why? |
| Peptidyl-Dipeptidase A | 4 | 2020 | 9659 | 0.09 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.09 | Why? |
| Virus Diseases | 2 | 2020 | 3779 | 0.09 | Why? |
| Microscopy, Confocal | 1 | 2010 | 343 | 0.09 | Why? |
| Genomics | 1 | 2020 | 3118 | 0.09 | Why? |
| History, 20th Century | 1 | 2014 | 1282 | 0.09 | Why? |
| Serologic Tests | 3 | 2020 | 4359 | 0.09 | Why? |
| Proteolysis | 3 | 2019 | 751 | 0.08 | Why? |
| Blood | 2 | 2020 | 274 | 0.08 | Why? |
| Endoplasmic Reticulum | 1 | 2010 | 430 | 0.08 | Why? |
| Ubiquitination | 2 | 2019 | 343 | 0.08 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.08 | Why? |
| Lysosomes | 1 | 2010 | 416 | 0.08 | Why? |
| Coronaviridae | 1 | 2013 | 923 | 0.08 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2008 | 635 | 0.08 | Why? |
| Viruses | 1 | 2020 | 2238 | 0.08 | Why? |
| Immunoglobulin M | 3 | 2020 | 9091 | 0.08 | Why? |
| Viral Structural Proteins | 1 | 2010 | 491 | 0.08 | Why? |
| Poxviridae | 1 | 2005 | 23 | 0.07 | Why? |
| Guanidines | 2 | 2020 | 499 | 0.07 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.07 | Why? |
| Urine | 2 | 2020 | 469 | 0.07 | Why? |
| Respiratory Tract Infections | 3 | 2014 | 6817 | 0.07 | Why? |
| False Positive Reactions | 2 | 2021 | 1338 | 0.07 | Why? |
| Cross Reactions | 3 | 2021 | 4374 | 0.07 | Why? |
| Qatar | 2 | 2019 | 784 | 0.07 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.07 | Why? |
| Lung | 4 | 2021 | 31049 | 0.07 | Why? |
| Farmers | 2 | 2017 | 280 | 0.06 | Why? |
| Yellow fever virus | 1 | 2005 | 205 | 0.06 | Why? |
| Disease Models, Animal | 1 | 2021 | 10998 | 0.06 | Why? |
| Virus Shedding | 2 | 2020 | 5834 | 0.06 | Why? |
| Herpesvirus 6, Human | 1 | 2005 | 162 | 0.06 | Why? |
| Prevalence | 4 | 2019 | 25773 | 0.06 | Why? |
| Adult | 17 | 2021 | 244371 | 0.06 | Why? |
| Kinetics | 2 | 2021 | 3238 | 0.06 | Why? |
| Antibody Formation | 1 | 2015 | 4038 | 0.06 | Why? |
| Mutation | 2 | 2020 | 12376 | 0.06 | Why? |
| Down-Regulation | 2 | 2019 | 1416 | 0.06 | Why? |
| Feces | 4 | 2020 | 4235 | 0.05 | Why? |
| Female | 18 | 2021 | 380317 | 0.05 | Why? |
| Male | 20 | 2021 | 367725 | 0.05 | Why? |
| Chromosomes, Artificial, Yeast | 1 | 2020 | 31 | 0.05 | Why? |
| Aged | 14 | 2021 | 215776 | 0.05 | Why? |
| United Arab Emirates | 2 | 2014 | 704 | 0.05 | Why? |
| Republic of Korea | 3 | 2019 | 5858 | 0.05 | Why? |
| CD3 Complex | 1 | 2021 | 237 | 0.05 | Why? |
| Sequence Analysis, DNA | 3 | 2019 | 2830 | 0.05 | Why? |
| Cattle | 2 | 2016 | 1336 | 0.05 | Why? |
| Ammonium Chloride | 1 | 2020 | 79 | 0.05 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.05 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.05 | Why? |
| Gabexate | 1 | 2020 | 88 | 0.05 | Why? |
| Base Sequence | 2 | 2020 | 3581 | 0.05 | Why? |
| Occupational Exposure | 2 | 2016 | 4742 | 0.05 | Why? |
| Reference Standards | 2 | 2019 | 1163 | 0.05 | Why? |
| Pharynx | 2 | 2020 | 1544 | 0.05 | Why? |
| Adolescent | 8 | 2021 | 86841 | 0.05 | Why? |
| Murinae | 1 | 2019 | 25 | 0.05 | Why? |
| Serology | 1 | 2019 | 60 | 0.05 | Why? |
| Vesiculovirus | 1 | 2020 | 153 | 0.05 | Why? |
| Macaca mulatta | 1 | 2010 | 3716 | 0.05 | Why? |
| Cytomegalovirus | 1 | 2005 | 600 | 0.05 | Why? |
| Cold Temperature | 1 | 2021 | 260 | 0.05 | Why? |
| Antibodies, Monoclonal | 2 | 2019 | 8041 | 0.05 | Why? |
| Leucine | 1 | 2020 | 121 | 0.05 | Why? |
| Antiviral Agents | 5 | 2017 | 41703 | 0.05 | Why? |
| Arvicolinae | 1 | 2019 | 49 | 0.05 | Why? |
| Genes, Viral | 1 | 2005 | 1428 | 0.05 | Why? |
| DNA-Directed RNA Polymerases | 1 | 2020 | 239 | 0.05 | Why? |
| Benzamidines | 1 | 2020 | 206 | 0.05 | Why? |
| Gene Knockdown Techniques | 1 | 2019 | 347 | 0.05 | Why? |
| Saccharomyces cerevisiae | 1 | 2020 | 339 | 0.04 | Why? |
| Convalescence | 2 | 2021 | 2829 | 0.04 | Why? |
| Models, Biological | 2 | 2020 | 4907 | 0.04 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 343 | 0.04 | Why? |
| Young Adult | 9 | 2021 | 93724 | 0.04 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.04 | Why? |
| Esters | 1 | 2020 | 300 | 0.04 | Why? |
| Viral Load | 4 | 2021 | 15850 | 0.04 | Why? |
| Sialic Acids | 1 | 2019 | 218 | 0.04 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.04 | Why? |
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2016 | 27 | 0.04 | Why? |
| Respiratory Insufficiency | 1 | 2018 | 7301 | 0.04 | Why? |
| In Vitro Techniques | 1 | 2020 | 1027 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2021 | 813 | 0.04 | Why? |
| Multigene Family | 1 | 2017 | 377 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Germany | 3 | 2021 | 9196 | 0.04 | Why? |
| Aged, 80 and over | 7 | 2021 | 88759 | 0.04 | Why? |
| Respiratory System | 2 | 2021 | 3213 | 0.04 | Why? |
| Models, Molecular | 1 | 2010 | 7616 | 0.04 | Why? |
| Sequence Homology, Nucleic Acid | 1 | 2016 | 368 | 0.04 | Why? |
| Rabbits | 1 | 2019 | 1171 | 0.04 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.04 | Why? |
| Binding Sites | 2 | 2019 | 6201 | 0.04 | Why? |
| Risk | 2 | 2019 | 5288 | 0.04 | Why? |
| Healthy Volunteers | 1 | 2020 | 1444 | 0.03 | Why? |
| Cross Infection | 1 | 2016 | 8675 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| False Negative Reactions | 1 | 2021 | 1785 | 0.03 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.03 | Why? |
| Cattle Diseases | 1 | 2016 | 294 | 0.03 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2017 | 13720 | 0.03 | Why? |
| Bronchioles | 1 | 2013 | 33 | 0.03 | Why? |
| COS Cells | 1 | 2013 | 157 | 0.03 | Why? |
| Acute Kidney Injury | 1 | 2013 | 5762 | 0.03 | Why? |
| Selection, Genetic | 1 | 2017 | 691 | 0.03 | Why? |
| Hot Temperature | 1 | 2021 | 1299 | 0.03 | Why? |
| Receptors, Interferon | 1 | 2012 | 64 | 0.03 | Why? |
| Tacrolimus Binding Proteins | 1 | 2012 | 15 | 0.03 | Why? |
| Disease Outbreaks | 2 | 2018 | 27595 | 0.03 | Why? |
| Cross-Sectional Studies | 3 | 2017 | 53120 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2020 | 1074 | 0.03 | Why? |
| Nose | 1 | 2018 | 1093 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Endemic Diseases | 1 | 2016 | 480 | 0.03 | Why? |
| Coronavirus OC43, Human | 1 | 2020 | 1157 | 0.03 | Why? |
| Sheep | 1 | 2013 | 420 | 0.03 | Why? |
| Two-Hybrid System Techniques | 1 | 2011 | 116 | 0.03 | Why? |
| Immunity, Humoral | 2 | 2021 | 4849 | 0.03 | Why? |
| Camelids, New World | 1 | 2013 | 276 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2019 | 1265 | 0.03 | Why? |
| Population Surveillance | 2 | 2021 | 4967 | 0.03 | Why? |
| Virus Cultivation | 1 | 2015 | 579 | 0.03 | Why? |
| Sputum | 1 | 2020 | 1720 | 0.03 | Why? |
| Asia | 1 | 2019 | 2399 | 0.03 | Why? |
| Jurkat Cells | 1 | 2011 | 273 | 0.03 | Why? |
| Astroviridae | 1 | 2011 | 57 | 0.03 | Why? |
| Rats | 1 | 2019 | 2764 | 0.03 | Why? |
| Protein Processing, Post-Translational | 1 | 2014 | 634 | 0.03 | Why? |
| Protein Binding | 2 | 2019 | 11430 | 0.03 | Why? |
| Peptide Fragments | 1 | 2021 | 2075 | 0.03 | Why? |
| STAT1 Transcription Factor | 1 | 2012 | 313 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.03 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2012 | 610 | 0.03 | Why? |
| Child, Preschool | 4 | 2017 | 36283 | 0.03 | Why? |
| Bayes Theorem | 1 | 2019 | 3237 | 0.03 | Why? |
| Linear Models | 1 | 2016 | 1914 | 0.03 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.03 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2005 | 6740 | 0.02 | Why? |
| Protein Interaction Mapping | 1 | 2011 | 487 | 0.02 | Why? |
| Cell Membrane | 1 | 2014 | 743 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2020 | 2262 | 0.02 | Why? |
| Syndrome | 1 | 2014 | 1310 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2021 | 3444 | 0.02 | Why? |
| Swine | 1 | 2017 | 3352 | 0.02 | Why? |
| Cyclosporine | 1 | 2011 | 449 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2016 | 3608 | 0.02 | Why? |
| Longitudinal Studies | 2 | 2016 | 9893 | 0.02 | Why? |
| Population Dynamics | 1 | 2011 | 378 | 0.02 | Why? |
| Zika Virus | 1 | 2020 | 1924 | 0.02 | Why? |
| Mice, Knockout | 1 | 2012 | 1815 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2020 | 3607 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2020 | 3614 | 0.02 | Why? |
| Ghana | 1 | 2009 | 763 | 0.02 | Why? |
| Health Personnel | 1 | 2016 | 29646 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| TATA-Box Binding Protein | 1 | 2005 | 3 | 0.02 | Why? |
| Peptidylprolyl Isomerase | 1 | 2005 | 10 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Child | 4 | 2017 | 70012 | 0.02 | Why? |
| Adenoviridae | 1 | 2011 | 1151 | 0.02 | Why? |
| Genetic Variation | 1 | 2019 | 3919 | 0.02 | Why? |
| Fever | 1 | 2021 | 7795 | 0.02 | Why? |
| Family Characteristics | 1 | 2014 | 2551 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2013 | 2290 | 0.02 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.02 | Why? |
| Fatal Outcome | 1 | 2013 | 3438 | 0.02 | Why? |
| Shock, Septic | 1 | 2013 | 1313 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2019 | 11304 | 0.02 | Why? |
| Immune Evasion | 1 | 2013 | 2081 | 0.01 | Why? |
| Drug Evaluation, Preclinical | 1 | 2014 | 3347 | 0.01 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 3633 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2021 | 6153 | 0.01 | Why? |
| Europe | 1 | 2019 | 12702 | 0.01 | Why? |
| Mice, Inbred C57BL | 1 | 2012 | 5542 | 0.01 | Why? |
| Anti-Infective Agents | 1 | 2013 | 1766 | 0.01 | Why? |
| Disease Susceptibility | 1 | 2014 | 4002 | 0.01 | Why? |
| Gene Expression | 1 | 2011 | 3332 | 0.01 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.01 | Why? |
| DNA, Viral | 1 | 2011 | 2521 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2018 | 8248 | 0.01 | Why? |
| RNA, Messenger | 1 | 2013 | 5131 | 0.01 | Why? |
| Viral Nonstructural Proteins | 1 | 2016 | 4810 | 0.01 | Why? |
| Recombinant Proteins | 1 | 2008 | 3786 | 0.01 | Why? |
| Mothers | 1 | 2008 | 1624 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Mass Screening | 1 | 2016 | 8005 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Nucleocapsid Proteins | 1 | 2008 | 3120 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Mice | 1 | 2012 | 21357 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Antigens, Viral | 1 | 2008 | 6298 | 0.01 | Why? |
| Cytokines | 1 | 2013 | 15010 | 0.01 | Why? |
| Infant, Newborn | 1 | 2008 | 23105 | 0.01 | Why? |
| Retrospective Studies | 1 | 2017 | 105322 | 0.00 | Why? |
| Infant | 1 | 2008 | 30274 | 0.00 | Why? |